Literature DB >> 24141275

Health-related quality of life and its relation to disease severity in boys with Duchenne muscular dystrophy: satisfied boys, worrying parents--a case-control study.

S L S Houwen-van Opstal1, M Jansen2, N van Alfen3, I J M de Groot2.   

Abstract

The progression of Duchenne muscular dystrophy is expected to negatively influence the patients' health-related quality of life, but knowledge of the relationship with disease severity is limited. We investigated the relationship between health-related quality of life (KIDSCREEN-52 questionnaire) and disease severity (clinical assessments of body functions and activities) in 40 boys with Duchenne muscular dystrophy (19 ambulant, 21 wheelchair dependent) who were in different phases of the disease and underwent life-limiting events such as the loss of the ability to ambulate and the ability to lift the arms. In addition, we compared boys' health-related quality of life perceptions with that of their parents. The participants' health-related quality of life was similar to healthy peers' and not influenced by disease severity, except for the physical domain. Parents scored much lower than the boys on the KIDSCREEN-52 domains Self Perception, Moods and Emotions, and Bullying. The latter finding needs attention in the management of Duchenne muscular dystrophy.
© The Author(s) 2013.

Entities:  

Keywords:  ICF model; KIDSCREEN-52; child report; proxy report

Mesh:

Year:  2013        PMID: 24141275     DOI: 10.1177/0883073813506490

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Patterns of decline in upper limb function of boys and men with DMD: an international survey.

Authors:  Mariska M H P Janssen; Arjen Bergsma; Alexander C H Geurts; Imelda J M de Groot
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.

Authors:  Christiane Otto; Birgit F Steffensen; Ann-Lisbeth Højberg; Claus Barkmann; Jes Rahbek; Ulrike Ravens-Sieberer; Annette Mahoney; Julia Vry; Kathrin Gramsch; Rachel Thompson; Sunil Rodger; Kate Bushby; Hanns Lochmüller; Janbernd Kirschner
Journal:  J Neurol       Date:  2017-02-07       Impact factor: 4.849

Review 3.  Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.

Authors:  Shalvaree Vaidya; Stefan Boes
Journal:  Qual Life Res       Date:  2018-07-24       Impact factor: 4.147

4.  Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study.

Authors:  Erik Landfeldt; Peter Lindgren; Christopher F Bell; Michela Guglieri; Volker Straub; Hanns Lochmüller; Katharine Bushby
Journal:  Dev Med Child Neurol       Date:  2015-10-19       Impact factor: 5.449

5.  Health-Related Quality of Life in Children with Duchenne Muscular Dystrophy: A Review.

Authors:  Yi Wei; Kathy Speechley; Craig Campbell
Journal:  J Neuromuscul Dis       Date:  2015-09-02

6.  An Unusual Triad in Pediatric Neurology: A Case Report on Cerebral Palsy, Epilepsy, and Duchenne Muscular Dystrophy.

Authors:  Ruben G F Hendriksen; Marlien W Aalbers; Jos G M Hendriksen; Christine E M de Die-Smulders; Govert Hoogland; Johan S H Vles
Journal:  Child Neurol Open       Date:  2016-04-19

Review 7.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.

Authors:  S Ryder; R M Leadley; N Armstrong; M Westwood; S de Kock; T Butt; M Jain; J Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

8.  Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.

Authors:  Rianne J M Goselink; Tim H A Schreuder; Nens van Alfen; Imelda J M de Groot; Merel Jansen; Richard J L F Lemmers; Patrick J van der Vliet; Nienke van der Stoep; Thomas Theelen; Nicol C Voermans; Silvère M van der Maarel; Baziel G M van Engelen; Corrie E Erasmus
Journal:  Ann Neurol       Date:  2018-10-16       Impact factor: 10.422

9.  Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.

Authors:  C L Wood; T D Cheetham; K G Hollingsworth; M Guglieri; Y Ailins-Sahun; S Punniyakodi; A Mayhew; V Straub
Journal:  BMC Pediatr       Date:  2019-04-25       Impact factor: 2.125

10.  Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?

Authors:  Susan Sienko; Cathleen Buckon; Eileen Fowler; Anita Bagley; Loretta Staudt; Mitell Sison-Williamson; Kathy Zebracki; Craig M McDonald; Michael Sussman
Journal:  PLoS Curr       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.